WCLC 2025 - Posters & ePosters-P3.18.11 Adding Certolizumab to Neoadjuvant Chemoimmunotherapy - Control of Immune-Related Adverse Events and Prevention of Surgical Delays

P3.18.11 Adding Certolizumab to Neoadjuvant Chemoimmunotherapy - Control of Immune-Related Adverse Events and Prevention of Surgical Delays

Asset Subtitle

Paul Paik

Meta Tag

Speaker Paul Paik

Topic Clinical Trials in Progress